- Home
- NRXS
NRXS
Neuraxis Inc.
as 07-26-2024 4:00pm EST
Stocks
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | CARMEL |
| Market Cap: | 20.3M | IPO Year: | 2023 |
| Target Price: | N/A | AVG Volume (30 days): | 6.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.73 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.80 - $6.93 | Next Earning Date: | 08-15-2024 |
| Revenue: | $2,301,575 | Revenue Growth: | -15.37% |
| Revenue Growth (this year): | 383.16% | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Neuraxis Inc. (NRXS)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hannasch Brian | NRXS | 10% Owner | Dec 28 '23 | Sell | $2.61 | 76 | $198.36 | 532,901 | SEC Form 4 |
Latest Neuraxis Inc. News
NRXS Breaking Stock News: Dive into NRXS Ticker-Specific Updates for Smart Investing
GuruFocus.com
2 months ago
Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares
GuruFocus.com
2 months ago
Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares
CNW Group
2 months ago
Gluckstein Lawyers Involved in Landmark Ruling Against Ukraine International Airlines in Flight PS 752 Case
Yahoo Finance Video
2 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
2 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Reuters
2 months ago
California seeks company profits in Big Oil climate lawsuit
USA TODAY
2 months ago
S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead
Business Wire
2 months ago
Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
Compare NRXS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NRXS Neuraxis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.